Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma

4 Mar 2019

Abstract excerpt

BACKGROUND: Lung cancer has become the most common cancer type and caused the most cancer deaths. Lung adenocarcinoma (LUAD) is one of the major type of lung cancer. This study aimed to establish a signature based on immune related genes that can predict patients' OS for LUAD. METHODS: The expression data of 976 LUAD patients from The Cancer Genome Atlas database (training set) and the Gene Expression Omnibus...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis
Share to Inflammasome and immune disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30832680
DOI: 10.1186/s12967-019-1824-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinomaPMID 30832680Read ↗

A new immune signature for survival prediction and immune checkpoint molecules in lung adenocarcinoma.Semantic proximity Read ↗

Exploration of the prognostic signature reflecting tumor microenvironment of lung adenocarcinoma based on immunologically relevant genesSemantic proximity Read ↗

Development of an Immune-Related Gene Pairs Signature for Predicting Clinical Outcome in Lung AdenocarcinomaSemantic proximity Read ↗

Development of an immune-related gene pairs signature for predicting clinical outcome in lung adenocarcinomaSemantic proximity Read ↗

An immune gene signature to predict prognosis and immunotherapeutic response in lung adenocarcinomaSemantic proximity Read ↗

Identification and validation of immune-related lncRNA prognostic signature for lung cancerSemantic proximity Read ↗

Individualized Prognostic Score for Lung Adenocarcinoma Based on Immune StatusSemantic proximity Read ↗

An Immune Gene Signature for Prediction of Overall Survival and Response to Immune Checkpoint Inhibitors Therapy in Patients with Lung AdenocarcinomaSemantic proximity Read ↗

Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosisSemantic proximity Read ↗

Immune signature-based risk stratification and prediction of immune checkpoint inhibitor's efficacy for lung adenocarcinoma.Semantic proximity Read ↗

Establishment and validation of an immune-associated signature in lung adenocarcinoma.Semantic proximity Read ↗

Identification and Validation of a Novel Prognostic Model of Inflammation-related Gene Signature of Lung AdenocarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.